Cargando…
Single-Cell Transcriptomics Reveals Killing Mechanisms of Antitumor Cytotoxic CD4(+) TCR-T Cells
T cell receptor-engineered T cells (TCR-Ts) have emerged as potent cancer immunotherapies. While most research focused on classical cytotoxic CD8(+) T cells, the application of CD4(+) T cells in adoptive T cell therapy has gained much interest recently. However, the cytotoxic mechanisms of CD4(+) TC...
Autores principales: | Liang, Yanling, Xu, Qumiao, Liu, Songming, Li, Jie, Wang, Fei, Li, Ziyi, Liao, Lijuan, Lu, Yuting, Li, Yijian, Mu, Feng, Sun, Hai-Xi, Zhu, Linnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343810/ https://www.ncbi.nlm.nih.gov/pubmed/35928827 http://dx.doi.org/10.3389/fimmu.2022.939940 |
Ejemplares similares
-
Single-cell transcriptome analysis of the heterogeneous effects of differential expression of tumor PD-L1 on responding TCR-T cells
por: Ding, Renpeng, et al.
Publicado: (2021) -
A single-cell approach to engineer CD8+ T cells targeting cytomegalovirus
por: Wang, Fei, et al.
Publicado: (2020) -
NK cells specifically TCR-dressed to kill cancer cells
por: Mensali, Nadia, et al.
Publicado: (2019) -
Potentiating the Antitumor Activity of Cytotoxic T Cells via the Transmembrane Domain of IGSF4 That Increases TCR Avidity
por: Kim, Hye-Ran, et al.
Publicado: (2021) -
Autophagic flux restoration of senescent T cells improves antitumor activity of TCR‐engineered T cells
por: Zhang, Chaoting, et al.
Publicado: (2022)